Department of Pharmacy, Islamia University, Bahawalpur-Pakistan.
Keywords: anti-tuberculosis drugs, drug induced hepatitis, extrapulmonary tuberculosis, hepatoxicity, isoniazid, pyrazinamide, rifampin, toxic hepatitis

Introduction: Tuberculosis (TB) infects one third of population, world over. Anti-tubercular like isoniazid, rifampicin and pyrazinamide are highly effective but hepatotoxic. Data on prevalence of anti-TB drug-induced hepatitis and contributing risk factors are scarce in Bahawalpur. This cross-sectional study was designed to look at the prevalence and promoting risk factors of druginduced hepatitis in the urban population of Bahawalpur district, Punjab- Pakistan. Methods: We examined a total of 1161 peoples (>15 years; 589 male and 572 female); divided into 3 groups i.e., young (1535 years), mature (3550 years) and old (>50 years). Population was compared in terms of demographical data and risk factors, such as age, gender, hepatitis B/C carrier, and pretreatment liver biochemistries (serum albumin, globulin, aspartate aminotransferase, alanine aminotransferase and bilirubin). Data was evaluated by 95% confidence interval. Differences were considered significant at p<0.05 and highly significant at p<0.001. Results: Out of 146 TB patients, 21 developed hepatitis. The prevalence of drug-induced hepatitis was 14.38%. Lower serum albumin (p<0.05), higher serum globulin (p<0.05), tuberculosis, hepatitis B/C and poverty were significant risk factors. Conclusion: ATB-induced hepatotoxicity was significantly frequent among the patients treated with ATB.

Article Information

Identifiers and Pagination:
First Page:221
Last Page:233
Publisher Id:JAppPharm (2011 ). 3. 221-233
Article History:
Received:January 6, 2011
Accepted:April 5, 2011
Collection year:2011
First Published:April 13, 2011

© 2016 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. You are free to: Share — copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
Editor in Chief
Prof. Dr. Cornelia M. Keck (Philipps-Universität Marburg)
Marburg, Germany


Welcome to the research group of Prof. Dr. Cornelia M. Keck in Marburg. Cornelia M. Keck is a pharmacist and obtained her PhD in 2006 from the Freie Universität (FU) in Berlin. In 2009 she was appointed as Adjunct Professor for Pharmaceutical and Nutritional Nanotechnology at the University Putra Malaysia (UPM) and in 2011 she obtained her Venia legendi (Habilitation) at the Freie Universität Berlin and was appointed as a Professor for Pharmacology and Pharmaceutics at the University of Applied Sciences Kaiserslautern. Since 2016 she is Professor of Pharmaceutics and Biopharmaceutics at the Philipps-Universität Marburg. Her field of research is the development and characterization of innovative nanocarriers for improved delivery of poorly soluble actives for healthcare and cosmetics. Prof. Keck is executive board member of the German Association of Nanotechnology (Deutscher Verband Nanotechnologie), Vize-chairman of the unit „Dermocosmetics“ at the German Society of Dermopharmacy, active member in many pharmaceutical societies and member of the BfR Committee for Cosmetics at the Federal Institute for Risk Assessment (BfR).

Journal Highlights
Abbreviation: J App Pharm
Frequency: Annual 
Current Volume: 9 (2017)
Next scheduled volume: December, 2018 (Volume 10)
Back volumes: 1-9
Starting year: 2009
Nature: Online 
Submission: Online  
Language: English

Subject & Scope
  • Pharmaceutics
  • Physical Pharmacy 
  • Dosage Forms Science 
  • Pharmaceutical Microbiology & Immunology 
  • Industrial Pharmacy 
  • Bio-Pharmaceutics 
  • Pharmaceutical Chemistry 
  • Pharmaceutical Instrumentation 
  • Medicinal Chemistry 
  • Pharmacognosy 
  • Physiology &Histology 
  • Anatomy & Pathology 
  • Pharmacology & Therapeutics 
  • Pharmacy Practice 
  • Pharmaceutical Mathematics   
  • Biostatistics 
  • Dispensing 
  • Community Social & Administrative Pharmacy 
  • Hospital Pharmacy 
  • Clinical Pharmacy 
  • Pharmaceutical Quality Management 
  • Forensic Pharmacy 
  • Pharmaceutical Technology 
  • Pharmaceutical Management & Marketing

Consortium Publisher is an online publisher that enjoys global presence with International Journals

Follow Us

©2009 - 2019 Consortium Publisher Canada

Contact Info

6252 Lisgar Dr Mississauga Ontario L5N7V2 Canada
+1 (647) 526-0885